The gene expression profile of Abca1 showed a trend similar to that of the Lxr s, but a significant reduction was only observed during long-term infection ( Fig. 5E ).
← all phrases
“showed a trend”
In the literature
Egr - 1 levels in the sampled areas of the Ptor showed a trend toward higher expression in response to the US versus the FS stimulus.
When expression of each receptor protein was suppressed by their specific siRNA, expression levels of the other two proteins showed a trend of down-regulation, with a higher correlation between c-Met and Axl (Figure 3B ).
Aristides showed a trend toward above chance performance when the area of the larger numerosity was greater than that of the smaller numerosity, but Teres accuracy did not exceed chance levels (Aristides: M = 62%, t (9) = 1.65, p = 0.07; Teres: M = 51%, t (9) = −0.57, p = 0.29).
Over-expression of sra35 (SRA35; Figure 7 ) resulted in up-regulation of glnA ( Figure 7 D), whereas two other targets ( ppiA and atpD ) showed a trend of down-regulation ( Figure 7 F and H).
In agreement with our multivariate analysis, the stratified analysis of PRNP G310C across the PRNP M129V genotypes showed a trend in all three strata to a higher proportion of individuals with PRNP 310C allele in the sCJD cases than in the controls.
Our results showed a trend of declining CD4 T cell levels with both of the viruses during the ten week period of evaluation.
Furthermore, sad mood showed a trend towards predicting left visual field omissions.
Interestingly, although a few of these genes showed a trend of increase also in monocytes and PBMC exposed in vitro to IFNγ, the induction was much stronger in terms of log ratio levels and more consistent among groups of samples treated with IFNα, confirming that these 64 genes can be considered the IFNα specific signature in human PBMC as well as monocytes.
M402 monotherapy showed a trend towards improved survival, but did not reach statistical significance in this study (p = 0.10 by Log-Rank test).
Further analyses showed a trend towards a moderator effect of perceived environmental sensitivity on the relation between perceived proximity to BS and NSPS.
Thus, although both analyses showed a trend toward lower hospitalization rates, the fact that the difference between patients allocated to different binders was of statistical significance in the analysis by Peter et al. was not considered robust.
The P value showed a trend of significant relationship as 11 C-choline > 18 F-FDG > 18 F-FAMT for distinguishing malignant tumors from benign lesions.
The interaction between PP2A A and C subunits showed a trend of 10% up-regulation in the 2 μM group.
This population showed a trend in the OR of rs2837960 that was consistent with that of the Stage 1 analysis (Table 5 ), i.e., the minor rs2837960_G allele appeared to impart an increased, although non-significant, risk of AD.
However, those comparisons that were not statistically significant in the pilot study due to small sample size but showed a trend toward predicted statistical significant differences with an increased sample size (based on the power calculation) were included in the experimental design.
Treatment with SD-282 at a low dose showed a trend toward reducing the inflammation but the difference was not significant.
Co-transfection of siRNA-Sp4 showed a trend to decreased levels of promoter activity that did not reach significance.
1B ), and showed a trend towards lower cell numbers in the draining lymph nodes of the genital tract ( Fig. 1B ).
However, examination of the individual patients' data showed a trend for no change in subjects presenting with low cGMP basal values (<1.5 fmol close to the detection limit), but a clear decrease (approximately 50%) after LD administration in subjects presenting with higher basal values (>3.0 fmol, patient-2 and 6; highlighted in Table 2 ).
Kaplan-Meier analysis showed a trend toward an increased OS rate for patients with hypomethylated CpG1, however, the difference did not reach statistical significance (P = 0.22, log-rank = 1.51; Figure 3 ).
In that head-to-head study (a 30-week, open-label trial that included 295 patients with Type 2 diabetes), patients’ treatment satisfaction was also measured by the DTSQ and, although the results showed a trend towards greater treatment satisfaction with exenatide once weekly vs. twice daily, the difference was not statistically significant [ 7 ].
Additionally, subjects with elevated baseline CRP and ESR showed a trend towards a reduction of circulating CRP levels or normalisation of ESR at least once within the first 4 weeks after administration.
The group with cerebral swelling was younger, had a higher opening pressure on lumbar puncture, and showed a trend to more frequent convulsions.
GRP94 was up-regulated by IFN treatment, and GRP78 showed a trend toward increased levels, but was determined to be not significant.